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ABSTRACT Septic or endotoxic shock is a common cause of death in hospital intensive care units. In the last decade
numerous antimicrobial peptides and proteins have been tested in the search for an efﬁcient drug to treat this lethal disease.
Now in phase III clinical trials, rBPI21, a recombinant N-terminal fragment of the bactericidal/permeability-increasing protein
(BPI), is a promising drug to reduce lesions caused by meningococcal sepsis. We correlated structural and stability data with
functional information of rBPI21 bound to both model systems of eukaryotic and bacterial membranes. On interaction with
membranes, rBPI21 loses its conformational stability, as studied by circular dichroism. This interaction of rBPI21 at membrane
level was higher in the presence of negatively charged phospholipid relatively to neutral ones, with higher partition coefﬁcients
(Kp), suggesting a preference for bacterial membranes over mammalian membranes. rBPI21 binding to membranes is reinforced
when its disulﬁde bond is broken due to conformational changes of the protein. This interaction is followed by liposome aggre-
gation due to unfolding, which ensures protein aggregation, and interfacial localization of rBPI21 in membranes, as studied
by extensive quenching by acrylamide and 5-deoxylstearic acid and not by 16-deoxylstearic acid. An uncommon model of
the selectivity and mechanism of action is proposed, where membrane induces unfolding of the antimicrobial protein, rBPI21.
The unfolding ensures protein aggregation, established by protein-protein interaction at membrane surface or between adjacent
membranes covered by the unfolded protein. This protein aggregation step may lead to membrane perturbation.INTRODUCTION
Gram-negative bacteria have two cell envelope membranes.
The outer membrane is asymmetric, with the glycolipid lipo-
polysaccharide (LPS) covering >90% of its outer leaflet
surface and the inner leaflet with a phospholipid composition
similar to the cytoplasmicmembrane (1,2). The highly packed
LPS moieties confer bacteria resistance to most antimicrobial
peptides. Nevertheless, many antimicrobial cationic peptides
have been shown to interact with LPS of Gram-negative
bacteria and sometimes pass across this membrane by self-
promoted uptake, followed by interaction and insertion into
the negatively charged cytoplasmic membrane (3,4). When
present in themammalian bloodstream, LPS elicits a common
but often fatal condition named septic or endotoxic shock,
characterized by hypotension and circulatory failure, which
can culminate inmultiple systemorgan failure.When in circu-
lation, LPS, complexed with several different proteins
(mainly lipopolysaccharide binding protein [LBP]), is recog-
nized by CD14 receptors in macrophages, monocytes or
neutrophils, which triggers a cascade of events that leads to
sepsis (5–7). Sepsis is a combination of both local and
systemic inflammatory responses, which requires a multi-
pronged interventional strategy to contain the various phases
of disease progression. LPS sequestration by small peptides or
proteins is an attractive interventional modality and many
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etc.) have intrinsic LPS binding activity (8–12). Most of these
peptides may form amphipathic helices. Their cationic nature
facilitates anchorage to the negatively charged bacterial
surface, whereas their amphiphilicity and high helical propen-
sity promote the formation of a-helices in membranes.
Moreover, the insertion of such amphipathic a-helices in
membranes underpins their membrane disruption activity.
Two related proteins, bactericidal/permeability-increasing
protein (BPI) and LBP are known to mediate the biological
effects of LPS and participate in the innate immune response
to bacterial infection in different ways (13–15). LBP
promotes LPS transfer to innate immune cells, activating
them, whereas BPI, present in azurophil granules of polymor-
phonuclear neutrophils, acts as a cytotoxic agent against
Gram-negative bacteria and neutralizing the toxicity of LPS
(16,17). The N-terminal fragment of BPI (rBPI21) not only
maintains the biological activity, neutralizing LPS (18–21),
but also represents a promising clinical tool to act against
meningitis and septic shock (22). rBPI21 is a recombinant
21 kDa truncated protein corresponding to amino acids
residues 1–193 of the N-terminal of human BPI (with the
exception that a cysteine is replaced by an alanine at position
132). Although various studies with BPI and its fragments
have been carried out, namely concerning antimicrobial
activity, there is still a great lack of information concerning
its mode of action, specially at membrane level. The interac-
tion of rBPI21 with negatively charged lipids was reported
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988 Domingues et al.(23,24) but detailed structural information on the interaction
with LPS is needed for the development of more effective
endotoxin-neutralizing agents.
In this study, fluorescence spectroscopy, circular dichroism
(CD) and light scattering were combined to systematically
study the interaction of rBPI21 with model systems of both
eukaryotic and bacterial membranes, mainly: 1), the role of
the disulfide bond and the selectivity to saccharide moiety of
LPS regarding bounding/recognition of LPS by rBPI21; 2),
temperature effects on thebinding tonegatively chargedgroups
of phospholipid bilayers; 3), the interaction withmembranes of
different compositions, as a key to understand the selectivity
toward bacteria and; 4), the rBPI21 conformational changes in
its interaction with phospholipid membranes and/or LPS.
MATERIALS AND METHODS
rBPI21, 99% pure, was a gift fromXOMALtd. (Berkeley, CA). All lipids were
obtained from Avanti Polar Lipids (Alabaster, AL), except LPS (Escherichia
coli O55:B5) that was purchased from Fluka (Buchs, Switzerland). Dodecyl
2,6-dideoxy-b-L-arabino-hexopyranoside (DAHP) was a kind gift from Prof.
PilarRauter (University ofLisbon,Portugal) and synthesized as described else-
where (25). Acetate buffer (5 mM sodium acetate, 150 mM NaCl) was used
in all the fluorescence studies. Sodium phosphate buffer was used instead of
acetate buffer in the CD studies to prevent significant absorption interferences.
Tris(2-cyanoethyl)phosphine (TCP) was from Molecular Probes (Eugene,
OR). 5-deoxylstearic acid (5NS), 16-deoxylstearic acid (16NS), guanidinium
chloride (GdnHCl), sodium phosphate, and all other chemicals were of the
highest commercially available purity and were purchased from Sigma (St.
Louis,MO).UV-Vis absorptionmeasurementswere carried out in a Shimadzu
spectrophotometer (model UV-3101 PC), unless otherwise stated. Fluores-
cence spectroscopy measurements were conducted on a spectrofluorimeter
SLM-Aminco 8100, equipped with a 450WXe Lamp and double monochro-
mators in both excitation and emission, as well as a quantum counter.
Large unilamellar vesicles preparation
Large unilamellar vesicles (LUV), with ~100 nm of diameter, were obtained
by extrusion of multilamellar vesicles as described elsewhere (26).
Fluorescence decays
Time-resolvedfluorescencedecaymeasurementswerecarriedout as described
previously (27) with a time-correlated single-photon counting system using
a Hamamatsu R-2809 MCP photomultiplier (Hamamatsu, Japan) for the
detection.Excitation andemissionwavelengthsof 285nmand308nm, respec-
tively, were chosen for rBPI21 studies. rBPI21, stock solution of 95.2 mM,
was added to previously prepared vesicle suspensions to a final concentration
of 0.7mM.Fluorescence decayswere complex and described by a sum of three
exponentials. The mean lifetime, t, was obtained from Eq. 1 (28):
t ¼
P
ait
2
iP
aiti
; (1)
where ai and ti are the pre-exponential factors and the fluorescence life-time
components, respectively.
The extent of incorporation of rBPI21 in model
system of eukaryotic and bacterial membranes
Partition studies were carried out in LUV, prepared using different lipids
(phospholipid þ glycolipid or phospholipid þ lipopolysaccharide). rBPI21
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measured with excitation and emission wavelengths of 295 nm and 338 nm,
respectively. The measured fluorescence intensity, If, is a balance between
the fluorescence intensities of the peptide in aqueous phase (IW) and inserted
in the lipid matrix (IL) as follows Eq. 2 (29). The weight factors in this
balance depend on the partition coefficient, Kp, which was calculated as
a fit parameter in a nonlinear regression methodology.
If
IW
¼ 1 þ KpgL½L

IL=IW

1 þ KpgL½L
(2)
Kp ¼
nS;L
VL
nS;W
VW
¼ ½PeptideL½PeptideW
; (3)
where [L] the lipid molar concentration and gL denotes the molar volume of
the lipid; nS,i are the moles of the solute present in each phase (i ¼ L and i ¼
W refer to the lipid and aqueous media, respectively).
In this work we studied the lipid phase influence on rBPI21 partition to
different model systems of membranes. We wanted to study not only the
influence of the lipid phase (liquid-crystalline versus gel) but also the
electrostatic effect (negative charged lipids versus zwitterionic lipids) and
the influence of different kinds of negatively charged lipid headgroups
(phosphatidylglycerol versus phosphatidylserine). Moreover we wanted to
compare LPS with an unrelated membrane bound saccharide (dihydroxyac-
etone phosphate [DHAP] versus LPS). palmitoyloleoylphosphatidylcholine
(POPC) and palmitoyloleoylphosphatidylglycerol (POPG) LUV are in
liquid-crystalline phase whereas dipalmitoylphosphatidylcholine (DPPC),
dipalmitoylphosphatidylglycerol (DPPG), and dipalmitoylphosphatidylserine
(DPPS) LUV are in gel phase at 25C and 37C.
Fluorescence quenching studies of rBPI21 in
aqueous phase and model system of bacterial
membranes
Acrylamide 8 M was used to quench rBPI21 fluorescence in the aqueous
phase. rBPI21 was dissolved in acetate buffer, pH 6.5 or 7.4. Aliquots of
acrylamide were added to the mixture up to 0.5 M and the fluorescence
intensity was measured at 325 nm. Quenching experiments with acrylamide
were carried out to study Trp residues exposure to the aqueous phase. Acryl-
amide was added to samples containing rBPI21 and LUV of phospholipids
with or without DAHP or LPS up to 0.5 M. Data treatment was as described
elsewhere (30). Fluorescence intensity was measured with excitation and
emission wavelengths of 295 nm and 330 nm, respectively. Differential
quenching studies were carried out to study the in-depth location of
rBPI21 in LUV of phospholipids with or without DHAP or LPS (both
were in final 5%, molar, of the total lipid concentration). These quenching
studies were carried out by adding small aliquots of 5NS or 16NS
(70 mM solutions in ethanol) to the suspension of LUV with rBPI21 added
previously. Ethanol was kept below 2% (v/v) to not affect lipid vesicles
structure. When inserted in lipid bilayers, 5NS and 16NS have doxyl moie-
ties close to the headgroup region and in the acyl chain region of the lipid
palisade, respectively.
The simplest model that describes dynamic or static fluorescence quench-
ing leads to linear Stern-Volmer plots:
I0
I
¼ 1 þ KSV½Q; (4)
where I0 and I denote the fluorescence intensities without and with quencher,
respectively, KSV is the Stern-Volmer constant and [Q] is the quencher
concentration. However, nonlinear Stern-Volmer plots are observed when
there are multiple classes of fluorophores (31), such as a fluorophore popu-
lation protected from the contact of the quencher and a population that is
accessible to it (32).
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in its structure in solution and in the extent
of incorporation in model systems of bacterial
membranes
TCP solution was prepared by dilution in acetate buffer. For modification
with TCP in solution, rBPI21 was dissolved in acetate buffer, pH 6.5 or
7.4. Aliquots of TCP were added to the mixture at fixed intervals and fluo-
rescence spectra were recorded. The final concentration of TCP ranged from
0.2 to 1.4 mM. To study the influence of a reduction in rBPI21 extent of
incorporation in model systems of bacterial membranes, rBPI21 was pre-
incubated with TCP (final concentration 1.4 mM) and added to LUV
composed of POPC/POPG/DAHP or POPC/POPG/LPS. Fluorescence
intensity was measured afterward and partition coefficients were calculated.
Conformational studies of rBPI21 in aqueous
phase and in model systems of bacterial
membranes by CD
Secondary structure analysis was carried out by far-UV (185–260 nm) CD in
a Jasco J810 Spectropolarimeter (Jasco, Japan) equipped with a temperature
control unit JulaboF25. FarUVCDspectrawere recordedwith 0.1 cm (linear)
path length quartz cuvette. For each spectrum, three scans were averaged.
rBPI21 samples in 20mMsodiumphosphate bufferwith 150mMsodiumfluo-
ride, pH 6.5 or 7.4, in the presence or absence of 0.1 mM lipid concentration
were equilibrated either at 25C or 37C, beforemeasurements.Minor contri-
butions of circular differential scattering were eliminated by subtracting the
CD spectrum of buffer and/or lipids from the peptide spectrum on buffer
and lipids, respectively.For rBPI21 secondary structure estimation,CDspectra
were deconvoluted using the CDSSTR algorithm (33) on Dichroweb (34).
Conformational stability measurements
rBPI21 conformational stability studies were carried out by CD in GdnHCl-
induced protein unfolding experiments either at 25C or 37C, at pH 6.5
and pH7.4, after 48 h of incubation. CDdenaturation curveswere constructed
using the ellipticity at 222 nm. A nonlinear least squares fitting procedure
yielded values forDG0(H2O), the conformational stability, andm, the depen-
dence of DG0 on denaturant concentration. Cm, the denaturant concentration
at the midpoint of the unfolding transition was calculated as Cm ¼
DG0ðH2OÞ=m and KU, the unfolding equilibrium constant, was calculated
as KU ¼ eDG0ðH2OÞ=RT (35). Denaturation curves for monomeric species
were analyzed considering the equation developed by Santoro and Bolen
(36). Parameters were obtained by fitting the derived equations to experi-
mental data by nonlinear regression using the solver add-on for Microsoft
Excel 2003 (Microsoft, Redmond, WA).
Aggregation of negatively charged vesicles in the
presence of rBPI21 by dynamic light scattering
Dynamic light scattering experimentswere carried out on aMalvern Zetasizer
Nano ZS (Malvern Instruments, Worcestershire, UK) with a backscattering
detection at 173 and equipped with He-Ne laser (l ¼ 632.8 nm), at 37C,
using disposable polystyrene cells. The phosphate buffer and lipid were
mixed and then filtered in a syringe filterwith pore size of 0.45mm(Whatman,
Florham Park, NJ). Lipid concentration was fixed at 50 mM and the rBPI21
concentrationwas varied from 24 nM to 238 nM. The sampleswere left equil-
ibrating for 30 min at 37C. Normalized intensity autocorrelation functions
were analyzed using the CONTIN method (37,38) yielding a distribution of
diffusion coefficients (D) in the whole solution through multiexponential
fits. The measured D is used for the calculation of the hydrodynamic radius
(RH) through the Stokes-Einstein relationship:
D ¼ kT=6phRH; (5)where k is the Boltzmann constant, T the absolute temperature, and h the
medium viscosity. The hydrodynamic diameter (DH) of the sample was
obtained from the peak with the highest scattered light intensity in light
scattering intensity distributions.
RESULTS AND DISCUSSION
Studies in aqueous solution
On excitation at l R 295 nm, the fluorescence of rBPI21 is
dominated by tryptophan fluorescence, either at pH 6.5 or
7.4. In buffer solution the Trp emission of rBPI21 occurs at
shorter wavelengths, relative to the emission of Trp in
aqueous environment (Table 1). This blue shift results from
the shielding of the Trp residues from water by the hydro-
phobic core of the folded peptide. BPI structure shows
a Trp residue in hydrophobic environment (39), which may
explain both this large blue shift and the increased fluores-
cence lifetime (Fig. 1). In buffer solution, intrinsic fluores-
cence emission was decreased for pH 6.5, although no shift
in the fluorescence spectra is observed. This result suggests
that a slightly acid pH induces conformational changes that
induce self-quenching but do not involve exposure of the
Trp residues to the aqueous medium.
TCPwas added to rBPI21 solution to study eventual changes
in theTrp environment after the breaking of the disulfide bond.
At pH 6.5 the emission maximum occurs at a higher wave-
length (Fig. 2 A), on addition of TCP. This red shift suggests
a change in the Trp residue environment to a more hydrophilic
one. This is a combined effect of lowering the pH, which is
close to histidines pKa, and disulfide bondbreaking.No signif-
icant differencewas observed in the emission spectra at pH7.4
(Fig. 2 B), on addition of TCP, which points out to the fact that
although disulfide bond reduction may induce conformational
changes, these do not globally affect the Trp environment at
this pH. These results in aqueous solution show that rBPI21
undergoes conformational changes when both acidification
and disulfide bond reduction occurs, where rBPI21 exposes
the Trp to a more hydrophilic environment.
rBPI21 conformation and stability in aqueous
buffer solution
To know if rBPI21 is folded at 37
C, thermal stability runs
followed by CD were carried out (results not shown). The
TABLE 1 Photophysical parameters for Trp and rBPI21, in
acetate buffer and in large unilamellar vesicles (5 mM), at pH 7.4
Parameters Trp rBPI21
lAbs/nm 280* 276
lEm/nm 348* 325
tW=ns 2.6* 5.7
tL=ns — 4.1
lAbs, lEm are maximum absorption and emission wavelengths, respectively,
and t is the mean fluorescence lifetime. [Trp]¼ 1.0 mM; [rBPI21]¼ 7.7 mM.
W and L subscripts denote aqueous and lipid environments, respectively.
*At 23C in aqueous solution at neutral pH (28).
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aqueous solution at 25C and 37C.
To address the importance of histidine protonation on the
rBPI21 structure, we have characterized the chemical confor-
mational stability of rBPI21 at pH 6.5 and 7.4. Fig. 3 shows the
equilibrium denaturation curves at pH 7.4 and 6.5 at 25C,
using guanidinium chloride (GdnHCl) as denaturant, moni-
tored by CD. The free energy of unfolding (DG0(H2O)) was
directly obtained by a nonlinear least-squares fit of the exper-
imental fluorescence data to a two-state model for monomer
unfolding (35,36). GdnHCl-induced denaturation of rBPI21
was found to be reversible for both pH values studied, as
judged by CD and fluorescence experiments. Analysis of
GdnHCl-unfolded rBPI21 samples after dialysis, by CD and
fluorescence, produced typical rBPI21 spectra parameters.
Table 2 shows the values obtained from the curves in Fig. 3
for DG0(H2O), the conformational stability, m, the depen-
dence of DG0 on denaturant concentration, and Cm, the
denaturant concentration at the midpoint of the unfolding
transition. The low values of DG0(H2O) for rBPI21 are well
within typical values of conformational stability for peptides
and truncated proteins.
The lower DG0(H2O) values obtained at pH 6.5 indicates
a decrease in the conformational stability of rBPI21 when
compared with the DG0(H2O) at pH 7.4 (Table 2). The
smaller value of the conformational stability of rBPI21 at
pH 6.5 agrees completely with the higher tendency for dena-
turation of rBPI21 at pH 6.5. Moreover, the denaturation
midpoint, Cm, also shows this tendency, confirming the
reduction of conformational stability on acidification.
It is worth noting that the slightly higher conformational
stability shown by rBPI21 at pH 7.4 is also due to a higher m
(Table 2). The m value is believed to reflect the extent of
newly exposed surface area on unfolding (40). Thus, the
higher m value observed for the unfolding of rBPI21 at
pH 7.4may indicate amore compact structurewhen compared
FIGURE 1 3D ribbon structure of the first 193 residues of BPI, corre-
sponding to the sequence of the rBPI21. Secondary structure of the a-helices
is represented in red online and black in print, b-sheets are in blue online and
dark gray in print. Phosphatidylcholine (yellow online and gray in print), is
localized in the hydrophobic pocket of the protein, and tryptophan residues
are represented in green online and as a ball and stick residue in print.
Structure based on the crystallographic structure of BPI (44).
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with the results obtained from fluorescence techniques.
Interaction of rBPI21 with model systems
of eukaryotic and bacterial membranes
Partition of rBPI21 into model systems of eukaryotic and
bacterial membranes was investigated from changes in the
rBPI21 intrinsic fluorescence, as described in Materials and
Methods. Table 3 shows that rBPI21 interacts more effectively
with negatively charged membranes in the gel crystalline
phase, the highest partition coefficients being obtained for
DPPG, at 37C, which may help to explain the preference of
rBPI21 for Gram-negative bacteria. These bacteria are known
FIGURE 2 rBPI21 (7.7mM)fluorescence emission spectra in acetate buffer
before and after incubationwith TCP (1.4mM). (A) pH 6.5. (B) pH 7.4. lexc¼
295 nm, at 37C. Similar spectra were obtained at 25C.
Fold-Unfold of rBPI21 991for having an asymmetric outer membrane in which>90% of
its outer leaflet surface is covered by LPS, which compared to
typical phospholipid membranes are known to have tighter
hydrocarbon chain packing and form rigid domains (41).
The preference of rBPI21 for gel phase membranes with
high density of negative charges is remarkable and parallels
rBPI21 selectivity for the external surface of the outer
membrane of gram-negative bacteria. The effect of charge
alone does not suffice to explain this selectivity, as the parti-
tion coefficient for fluid POPG bilayers is considerably lower
than the obtained for the rigid DPPG. Moreover, rBPI21 is
sensitive to the chemical nature of the headgroups. Kp differs
in mixtures containing PG and PS, where Kp(PG) > Kp(PS)
FIGURE 3 GdnHCl equilibrium denaturation curves of rBPI21 at pH 7.4
(A) and 6.5 (B), at 25C, monitored by CD at 222 nm. The curves are
nonlinear least squares fits of an equation representing the entire denatur-
ation curves, based on a two-state model and using the linear extrapolation
method to the experimental CD data (36). Insets represent the residues of the
fit to the experimental data.(Fig. 4). This is of particular importance because PG is the
major phospholipid component present in the cytoplasmic
membrane of bacteria.
However, similar partition coefficients are obtained when
LPS is replaced by an unrelated saccharide, which shows
that rBPI21 is rather insensitive to the glycidic group. POPC
is the major lipid component of eukaryotic membrane cells.
If we calculate the ratio Kp(glycolipid or LPS systems)/Kp(POPC)
for rBPI21 at physiological conditions (pH 7.4 and 37
C),
values between 52 and 100 are obtained, which show clearly
the preference of rBPI21 for bacterial membranes. Curiously,
for some lipid model systems higher partition coefficients
were obtained at pH 6.5, relative to pH 7.4 (data not shown).
Similar fluorescence emission and CD spectra were obtained
for rBPI21 at both pH values. However, a slight decrease in
fluorescence intensity without a spectral shift was observed
with pH decrease, which suggests that pH changes can induce
an approximation between Trp and intramolecular quencher
groups, rather than exposing Trp to the aqueous medium.
Nevertheless, the exposure of hydrophobic segments is prob-
ably involved in the interaction of rBPI21 with the target
membrane. This hydrophobic segments exposure hypothesis
provideswhatwe believe is a new insight, ifwe remember that
conformational stability studies (see section above) showed
that there is a slight conformational stability reduction on
acidification, and that at pH 6.5 rBPI21 has a slightly less
compact native state. Moreover, rBPI21 has several His resi-
dues near a tryptophan residue. As pH 6.5 is near the pKa
value for His residues, protonation of His residues could
generate positive charges on rBPI21, which may contribute
TABLE 2 Stability parameters for rBPI21 in aqueous solution,
at pH 6.5 and 7.4, obtained from a direct ﬁt of the experimental
data in Fig. 3 to a two-state unfolding model
pH DG0(H2O)/kcal.mol
1 Cm/M m/kcal.mol
2  L
6.5 2.05 1.90 1.07
7.4 2.68 2.04 1.31
DG0(H2O) is the free energy of unfolding, Cm, is the denaturant concentra-
tion at the midpoint of the unfolding transition, calculated as Cm ¼
DG0(H2O)/m, andm is the DG
0 dependence on the denaturant concentration.
TABLE 3 Partition coefﬁcients (Kp) for rBPI21 in different lipid
systems at pH 7.4 and 37C
System Kp  103
DPPG 13.65 5.00
DPPC/DPPG 9.755 1.82
DPPC/DPPS 3.985 1.18
DPPC 0.1235 0.054
POPG 0.8515 0.213
POPC z0
POPC/POPG/DAHP 0.525 0.17
POPC/POPG/LPS 1.125 0.073
POPC/POPG/DAHP (pre-incubated with TCP) 2.145 0.71
POPC/POPG/LPS (pre-incubated with TCP) 4.645 1.50
Anionic lipid contents in lipid mixtures: 50% molar; LPS or DAHP content
in mixtures: 5%.
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intercharge repulsion, and to the increase electrostatic interac-
tion required for protein membrane binding. Consequently,
Kp increases and potential quencher groups are formed.
Localization of rBPI21 in model systems
of bacterial membranes
The in-depth location of rBPI21 in the model systems of
bacterial membranes was studied by monitoring the relative
quenching of the fluorescence of this peptide by the lipo-
FIGURE 4 Determination of the partition constant (Kp) of the protein
between the aqueous phase and phospholipid vesicles. Peptide concentra-
tion, of 0.7 mM, was constant during each set of experiments. Increase in
fluorescence intensity obtained for different concentrations of (A) DPPC/
DPPG and (B) DPPC/DPPS LUV. Fitting lines calculated using Eq. 2.
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phase membranes of POPC/POPG/DAHP or POPC/POPG/
LPS mixtures. The addition of any of the two nitroxide
quenchers resulted in a decreased of rBPI21 fluorescence
intensity. The Stern-Volmer plots of the fluorescence inten-
sity changes were linear (Fig. 5), indicating that nearly all
rBPI21 is inserted in the membrane at the used lipid concen-
tration. The Stern-Volmer constants were obtained from their
slopes. The ratio of these slopes, KSV(5NS)/KSV(16NS) was
found to be always higher than 1, pointing toward a shallow
location of the peptide, except for the POPC/POPG system at
pH 7.4 (Table 4).
In the case of the two bacterial model membranes
composed of POPC/POPG/DAHP (or LPS) at physiological
conditions (pH 7.4 and 37C) the ratios obtained are quite
similar (2.25 and 2.74 for the glycolipid and the LPS con-
taining systems, respectively). This is indicative that
rBPI21 location is not LPS-specific.
To confirm the membrane location of rBPI21, we used the
hydrophilic quencher acrylamide, which quenches molecules
present in the aqueous phase or in the lipid/water interface.
rBPI21 is more extensively quenched by acrylamide in lipid
vesicles than in buffer solution, for all the lipid systems tested
(data not shown). This result is in agreement with a shallow
location of rBPI21 in lipid vesicles, with an extended confor-
mation where the Trp residues are relatively unshielded and
more exposed to the aqueous environment than in the
unbounded folded conformation. Tobias et al. (42) showed
that BPI can increase the apparent size of LPS aggregates at
1:20 BPI/LPS ratio. Our preliminary dynamic light scattering
experiments indicate a similar effect for rBPI21 onmembranes
composed of anionic phospholipids (Fig. 6). This means that
not only rBPI21 has the capacity of forming aggregates at a
lowmolar ratio but also that rBPI21 is capable of cross-linking
FIGURE 5 rBPI21 location. Stern-Volmer plots for the quenching of
rBPI21 fluorescence by 5NS in POPC/POPG/LPS (B) and POPC/POPG/
DAHP (-) membranes (1 mM), pH 7.4 and 37C. Effective 5NS concen-
trations in the membrane were calculated as described previously (52).
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induced by rBPI21 may be helpful for its in vivo function and
an explanation for its high biological activity. LPS interaction
with leukocytes can initiate an inflammatory responses, but
the LPS that binds to BPI is essentially inactive (43). This
capacity for inactivating LPS due to surface binding may
help to prevent septic shock. Partially unfolded proteins are
prone to aggregate. Likewise, vesicle aggregation may be
a direct consequence of partial unfolding.
Role of disulﬁde bond in rBPI21 interaction with
model systems of bacterial membranes
As the reduction of the disulfide bond between cysteines 135
and 175 with TCP is associated with a possible conforma-
tional change of the protein in buffer, we studied this effect
of the chemical change on the interaction with membranes.
rBPI21 partition to model system of bacterial membranes
under physiological conditions was increased (pH 7.4,
37C) (Table 3, Fig. 7). A fourfold increase of Kp is observed
for both membranes on disulfide bond breaking. Cysteines
TABLE 4 Location of rBPI21 in model systems of bacterial
membranes
System
KSV (pH 6.5) KSV (pH 7.4)
5NS 16NS 5NS 16NS
POPC/POPG 2.07 0.36 0.82 1.29
POPC/POPG/DAHP 2.25 1.83 4.11 1.83
POPC/POPG/LPS 2.86 0.36 4.60 1.68
Stern-Volmer constants (KSV) of rBPI21 were obtained as described in Mate-
rials and Methods using 5NS and 16NS quenchers at 37C, pH 6.5 and
pH 7.4 Anionic lipid contents in lipid mixtures: 40% molar; LPS or
DHAP content in mixtures: 5%.
FIGURE 6 Aggregation of membrane model systems by rBPI21. Hydro-
dynamic diameter variation followed by dynamic light scattering of POPC
(-) and POPC/POPG (,) membranes at fixed 50 mM lipid concentration,
with 45% molar of negative lipid content, in the presence of increasing
rBPI21 amount. Bars represents the size range from at least two independent
experiments.135 and 175 are both necessary for an efficient production
of a biologically active N-terminal BPI fragment, putatively
trough a disulfide bond (44), but at a certain cost in its LPS-
binding activity, because disulfide bond reduction can lead
to amore effective interactionwithmodel systems of bacterial
membranes.
The results are in agreement with a model of action that
involves unfolding/denaturation on interaction with in
LPS-containing membranes. A decrease in stability renders
the membrane disturbing effect more effective.
Conformational changes of rBPI21 after binding
to lipid membranes
According to theCDmeasurements, rBPI21 adopts a tridimen-
sional conformation with regular secondary structure in
aqueous buffer solution but forming a partial or total unfolded
structure in the presence of liposomes composed of POPC/
POPG/LPS, either at pH 6.5 or 7.4, at 25C and 37C
(Fig. 8). The CD spectra of rBPI21 in aqueous solution, both
at pH 6.5 and pH 7.4, at 25C and 37C, are similar and
display a positive ellipticity maximum near 194 nm and a
negative ellipticity minimum around 217 nm, evidence for
the presence of b-sheet conformation. In fact, secondary
structure estimation from CD spectra analysis showed 33%
of b-sheet, 14% of a-helix, and 30% random coil. Using
POPC/POPG/LPS 0.1 mM as a bacterial membrane
mimicking environment, rBPI21 completely loses its ordered
native conformation independently of the pH and/or temper-
ature (Fig. 8). CD spectra analysis showed a loss of secondary
structure, with a major decrease in the a-helix content. For
rBPI21 in interaction with POPC/POPG model systems of
membranes, a less intense positive and negative ellipticity
FIGURE 7 Implications of chemical modification on rBPI21 partition to
model system of bacterial membranes. rBPI21 was dissolved in acetate buffer
at pH 7.4 to a final protein concentration of 7.7 mM, and incubated with TCP
1.4 mM before partition coefficients determination, at 37C. Partition curves
of rBPI21 to POPC/POPG/DAHP LUV with (d) and without (B) pre-incu-
bation with TCP.Kp values are obtained by fitting the experimental data with
Eq. 2.Biophysical Journal 96(3) 987–996
994 Domingues et al.FIGURE 8 Effect of pH, temperature
and lipid system on the secondary struc-
ture of rBPI21. rBPI21 was dissolved in
phosphate buffer (pH 6.5 or 7.4), at
25C or 37C, to a final concentration
of 7.7 mM with or without added lipid
(0.1 mM). CD spectra of rBPI21 in (a)
buffer solution, and in interaction with
(b) POPC/POPG/DAHP or (c) POPC/
POPG/LPS membranes both at pH 6.5
and 7.4, and T ¼ 25C and 37C.and wavelengths slightly different from the ones observed in
aqueous solution were observed in CD spectra.
Typically, peptides such as antimicrobial peptides, for
instance, adopt a helical structure when interacting with lipid
vesicles and not the other way around. Nevertheless, this high
structure flexibility and low chemical conformational stability
probably imply the loss of the hydrophobic pocket, because it
is composed mainly by a-helix (44), which decreases in
proportion with its increasing contact with lipid membranes.
This represents further evidence that the exposure of this
segment (hidden in the three-dimensional structure of
rBPI21 in the aqueous phase) is a key-step in an innovative
model mechanism for peptide-membrane interaction. The
exposure of this segment to membranes decreases the mean
fluorescence lifetime of rBPI21 (Table 1), which implies that
Trp environment changes to a more hydrophilic one. More-
over, this flexibility may be the reason why rBPI21 can coat
LPS containing vesicles and, consequently, be effective
in inactivating the inflammatory cascade in vivo, in a first
stage.
CONCLUSIONS
We have shown that rBPI21 in solution is stable at 37
C and
has a higher chemical conformational stability at pH 7.4,
when compared with a more acidic pH. It undergoes confor-
mational changes when its disulfide bond is broken or pH
decreases, exposing its Trp to a more hydrophilic environ-
ment when both changes occur. When in interaction with
Biophysical Journal 96(3) 987–996model systems of membranes, rBPI21 interacts preferentially
with rigid negatively charged membranes, this being one of
the reasons that may be invoked for its preference for gram-
negative bacteria. Also, rBPI21 has a shallow location and
completely loses its secondary structure, unfolding, while
coating and aggregating LPS-containing vesicles (Fig. 8).
rBPI21 is at variance with most of antimicrobial peptides
that adopt a helical structure when inserted in the lipid bilayer.
This may be related to a peculiar mechanism of action, where
coating and aggregation of LPS-containing entities is of first
importance for their neutralization. We have also shown
that decreasing the pH, near the pKa of His, is important for
rBPI21 interaction with membranes and that the breaking of
the disulfide bond may enhance its LPS-binding activity
in vivo, as a consequence of a significant increase of partition
coefficients. Although there are some studies of rBPI21 in
interaction with lipid systems (23,24), to our knowledge no
one has identified specific amino acid residues implication
in this process.
The CD spectra results have shown that rBPI21 has a
predominant b-sheet secondary structure content. The results
on chemical conformational stability at pH 7.4 and 6.5
contribute to explain the partial and total loss of structure of
rBPI21 after binding to POPC/POPG/LPS liposomes at
pH 7.4 and 6.5, respectively. The lower rBPI21 conforma-
tional stability value at pH6.5 completely agreeswith a higher
loss of structure. Moreover, partial or total unfolded proteins
are prone to form aggregates, which could explain liposome
aggregation in the presence of rBPI21.
Fold-Unfold of rBPI21 995In summary, the results of this study highlight structural
reasons that may be responsible for the selectivity of
rBPI21 for Gram-negative bacteria and show that unfolding
at the surface of the membrane, on interaction with LPS is
an uncommon key-event of its mechanism (Fig. 9). Antimi-
crobial peptides are portrayed usually as molecules unstruc-
tured in solution, which gain structure when in contact with
the membrane. Peptide-peptide interactions are then trig-
gered at certain critical concentrations (45–51), which lead
to supramolecular entities that cause lysis, such as a variety
of pore-forming structures. rBPI21 seems to be quite peculiar
as its mode of action is not at all related to this sequence of
events from the start. It loses structure and stability on
contact with LPS membranes and is able to cause membrane
aggregation, which is quite perturbing for membranes and
FIGURE 9 Schematic representation of the proposed mechanism of
action of rBPI21 protein. The protein interacts superficially with LPS-rigid
regions of the membrane of gram-negative bacteria. This interaction is fol-
lowed by the unfolding of the protein covering the surface of the cell, leading
to severe membrane perturbation.ultimately responsible for the bactericidal activity of this
drug.
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